Gene · 4016
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research progress on the role of lncRNA-miRNA networks in regulating adipogenic and osteogenic differentiation of bone marrow mesenchymal stem cells in osteoporosis. | Front Endocrinol (Lausanne) | 2023 | 37645421 | PubTator, text mining | PubMed |
| A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. | Nat Cancer | 2023 | 37640930 | PubTator, text mining | PubMed |
| Pseudoexfoliation Glaucoma: Clinical Presentation and Therapeutic Options. | Turk J Ophthalmol | 2023 | 37602651 | PubTator, text mining | PubMed |
| Correlation between retinal nerve fiber layer thickness and anterior segment parameters in patients with pseudoexfoliation: A cross-sectional comparative study. | Oman J Ophthalmol | 2023 | 37602158 | PubTator, text mining | PubMed |
| PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer. | PLoS One | 2023 | 37582104 | PubTator, text mining | PubMed |
| Therapeutic implications for localized prostate cancer by multiomics analyses of the ageing microenvironment landscape. | Int J Biol Sci | 2023 | 37564213 | PubTator, text mining | PubMed |
| A Study on the Candidate Gene Association and Interaction with Measures of UV Exposure in Pseudoexfoliation Patients from India. | Curr Eye Res | 2023 | 37556844 | PubTator, text mining | PubMed |
| COVPRIG robustly predicts the overall survival of IDH wild-type glioblastoma and highlights METTL1+ neural-progenitor-like tumor cell in driving unfavorable outcome. | J Transl Med | 2023 | 37553713 | PubTator, text mining | PubMed |
| Lysyl oxidase-like 1-antisense 1 (LOXL1-AS1) lncRNA differentially regulates gene and protein expression, signaling and morphology of human ocular cells. | Hum Mol Genet | 2023 | 37540217 | PubTator, text mining | PubMed |
| Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment. | Front Cell Dev Biol | 2023 | 37538397 | PubTator, text mining | PubMed |
| Prevalence of pseudoexfoliation in diabetic patients with senile cataract: A hospital-based study in Kashmir, India. | Indian J Ophthalmol | 2023 | 37530270 | PubTator, text mining | PubMed |
| Multi-omics in thoracic aortic aneurysm: the complex road to the simplification. | Cell Biosci | 2023 | 37475058 | PubTator, text mining | PubMed |
| Targeting lysyl-oxidase (LOX) may facilitate intramural periarterial drainage for the treatment of Alzheimer's disease. | Cereb Circ Cogn Behav | 2023 | 37457664 | PubTator, text mining | PubMed |
| Exploring the Interplay between Polyphenols and Lysyl Oxidase Enzymes for Maintaining Extracellular Matrix Homeostasis. | Int J Mol Sci | 2023 | 37446164 | PubTator, text mining | PubMed |
| Soft Tissue Ewing Sarcoma Cell Drug Resistance Revisited: A Systems Biology Approach. | Int J Environ Res Public Health | 2023 | 37444135 | PubTator, text mining | PubMed |
| Exploration of Mediators Associated with Myocardial Remodelling in Feline Hypertrophic Cardiomyopathy. | Animals (Basel) | 2023 | 37443910 | PubTator, text mining | PubMed |
| Cell Cycle-Related lncRNAs as Innovative Targets to Advance Cancer Management. | Cancer Manag Res | 2023 | 37426392 | PubTator, text mining | PubMed |
| Clinical profile and demographic distribution of pseudoexfoliation syndrome: An electronic medical record-driven big data analytics from an eye care network in India. | Indian J Ophthalmol | 2023 | 37417115 | PubTator, text mining | PubMed |
| LINC00638 promotes the progression of non-small cell lung cancer by regulating the miR-541-3p/IRS1/PI3K/Akt axis. | Heliyon | 2023 | 37408901 | PubTator, text mining | PubMed |
| Treatment of liver fibrosis: Past, current, and future. | World J Hepatol | 2023 | 37397931 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4016/papers?page=10